BRITISH COLUMBIA, Canada--(BUSINESS WIRE)--InNexus Biotechnology Inc. (TSX Venture:IXS)(OTCBB:IXSBF), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL™) technology, announces Jeff Morhet will be presenting at BIO-Europe Spring 2007, Milano Convention Center, Milan, Italy, on Wednesday, March 7, 2007 at 10:30 AM.
